ArticleSexual medicine2017
Vaginismus Treatment: Clinical Trials Follow Up 241 Patients.
Article in Sexual medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Open Label, Single Center, Pilot Study of the Use of BOTOX Injections, Sensorcaine Injections and Progressive Dilation Under Anesthesia for the Treatment of Primary Vaginismus
Experience of Vaginismus in Outpatient Attendants in Assiut University Women's Health Hospital: Prevalence, Impact on Quality of Life and Management
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.
- The effect of biofeedback interventions on pain, overall symptoms, quality of life and physiological parameters in patients with pelvic pain : A systematic review.Wiener klinische Wochenschrift · 2022Pooled it
- Biofeedback versus electrical stimulation for sexual dysfunction: a randomized clinical trial.International urogynecology journal · 2021Trial
- Comparing the effectiveness of functional electrical stimulation via sexual cognitive/behavioral therapy of pelvic floor muscles versus local injection of botulinum toxin on the sexual functioning of patients with primary vaginismus: a randomized clinical trial.International urogynecology journal · 2019Trial
- Current and future pharmacotherapy for female sexual dysfunction.Nature reviews. Urology · 2026Review
- Managing Vaginismus with Assisted Dilatation Multidisciplinary Protocol - Retrospective Cohort Study from Indonesia's Largest Dedicated Centre.International journal of women's health · 2026Article
- Examination of sexual health literacy and cyberchondria levels in women with vaginismus.Turkish journal of medical sciences · 2026Article
- Sexual Dysfunction in Alopecia Areata: A Systematic Review.Journal of clinical medicine · 2025Review
- Evaluating the Effectiveness of Radiofrequency in Multimodal Physiotherapy for Postpartum Pelvic Pain: The RASDOP Protocol-A Mixed-Methods Study.Journal of clinical medicine · 2025Article
- Botulinum toxin treatment of refractory vaginismus: a prospective study.International journal of women's dermatology · 2024Article
- Patients' recommendations to improve help-seeking for vaginismus: a qualitative study.BMC women's health · 2024Article
- The interrelationship between women's help-seeking experiences for vaginismus and their sense of self: a qualitative study and abductive analysis.Health psychology and behavioral medicine · 2024Article
- Article
- Psychometric properties of the Romanian version of the female sexual function index (FSFI-RO).BMC women's health · 2023Article
- Clinical Features of Women with Genito-Pelvic Pain, Penetration Disorder and Disordered Eating Attitudes: A Cross Sectional Study.Noro psikiyatri arsivi · 2023Article
- Article
- The role of personal factors in quality of life among Iranian women with vaginismus: a path analysis.Health and quality of life outcomes · 2021Article
- Materials Selection for the Injection into Vaginal Wall for Treatment of Vaginal Atrophy.Aesthetic plastic surgery · 2021Review
- Botulinum injections for myofascial pelvic pain.International urogynecology journal · 2021Observational
- Article
- Effects of predisposing factors on the success and treatment period in vaginismus.JBRA assisted reproduction · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionVaginismus is mostly unknown among clinicians and women. Vaginismus causes women to have fear, anxiety, and pain with penetration attempts.
aimTo present a large cohort of patients based on prior published studies approved by an institutional review board and the Food and Drug Administration using a comprehensive multimodal vaginismus treatment program to treat the physical and psychologic manifestations of women with vaginismus and to record successes, failures, and untoward effects of this treatment approach.
methodsAssessment of vaginismus included a comprehensive pretreatment questionnaire, the Female Sexual Function Index (FSFI), and consultation. All patients signed a detailed informed consent. Treatment consisted of a multimodal approach including intravaginal injections of onabotulinumtoxinA (Botox) and bupivacaine, progressive dilation under conscious sedation, indwelling dilator, follow-up and support with office visits, phone calls, e-mails, dilation logs, and FSFI reports.
main outcome measuresLogs noting dilation progression, pain and anxiety scores, time to achieve intercourse, setbacks, and untoward effects. Post-treatment FSFI scores were compared with preprocedure scores.
resultsOne hundred seventy-one patients (71%) reported having pain-free intercourse at a mean of 5.1 weeks (median = 2.5). Six patients (2.5%) were unable to achieve intercourse within a 1-year period after treatment and 64 patients (26.6%) were lost to follow-up. The change in the overall FSFI score measured at baseline, 3 months, 6 months, and 1 year was statistically significant at the 0.05 level. Three patients developed mild temporary stress incontinence, two patients developed a short period of temporary blurred vision, and one patient developed temporary excessive vaginal dryness. All adverse events resolved by approximately 4 months. One patient required retreatment followed by successful coitus.
conclusionA multimodal program that treated the physical and psychologic aspects of vaginismus enabled women to achieve pain-free intercourse as noted by patient communications and serial female sexual function studies. Further studies are indicated to better understand the individual components of this multimodal treatment program. Pacik PT, Geletta S. Vaginismus Treatment: Clinical Trials Follow Up 241 Patients. Sex Med 2017;5:e114-e123.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.